3 Mins Read Nuritas, a biotech company developing plant-based peptides, has closed its $45 million Series B round. The company, which lists Bono and The Edge of U2 fame among its key backers, says the financing will accelerate its global expansion and help unlock more plant peptides that can be used to develop sustainable functional foods, supplements and […]

The post This Plant-Based Peptide Company Backed By U2’s Bono and The Edge Just Bagged $45M appeared first on Green Queen.

This post was originally published on Green Queen.